Receptor transactivation cascades. Focus on "effects of α1D-adrenergic receptors on shedding of biologically active EGF in freshly isolated lacrimal gland epithelial cells"

American Journal of Physiology - Cell Physiology

Volumn 292, Issue 1, 2007, Pages

  Snider, Ashley C ^a   Meier, Kathryn E ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR RECEPTOR; MATRIX METALLOPROTEINASE; NEUROTROPHIN RECEPTOR; PROTEIN KINASE C; PROTEIN TYROSINE KINASE;

CANCER CELL; CELL PROLIFERATION; EDITORIAL; EPITHELIUM CELL; HUMAN; LACRIMAL GLAND; MITOGENESIS; PARASYMPATHETIC NERVE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SYMPATHETIC NERVE; TUMOR CELL;

ANIMALS; CELL SEPARATION; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; HUMANS; LACRIMAL APPARATUS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ADRENERGIC, ALPHA-1; TRANS-ACTIVATION (GENETICS);

EID: 33846320461     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00364.2006     Document Type: Editorial

References (43)

1. Altavilla G, Castellan L, Wabersich J, Marchetti M, Onnis A. Prognostic significance of epidermal growth factor receptor (EGFR) and c-erbB-2 protein overexpression in adenocarcinoma of the uterine cervix. Eur J Gynaecol Oncol 17: 267-270, 1996.
2. Amos S, Martin PM, Polar GA, Parsons SJ, Hussaini IM. Phorbol 12-myristate 13-acetate induces epidermal growth factor receptor transactivation via protein kinase Cδ/c-Src pathways in glioblastoma cells. J Biol Chem 280: 7729-7738, 2005.
3. Arthur DB, Akassoglou K, Insel PA. P2Y2 and TrkA receptors interact with Src family kinase for neuronal differentiation. Biochem Biophys Res Commun 347: 678-682, 2006.
4. Filardo EJ. Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer. J Steroid Biochem Mol Biol 80: 231-238, 2002.
5. 1D-adrenergic receptors on shedding of biologically active EGF in freshly isolated lacrimal gland epithelial cells. Am J Physiol Cell Physiol 291: C946-C956, 2006.
6. Fischer OM, Hart S, Gschwind A, Ullrich A. EGFR signal transactivation in cancer cells. Biochem Soc Trans 31: 1203-1208, 2003.
7. Fischer OM, Hart S, Ullrich A. Dissecting the epidermal growth factor receptor signal transactivation pathway. Methods Mol Biol 327: 85-97, 2006.
8. Go M, Go P, Luttrell LM, Raymond JR. 5-HT2A receptor induces ERK phosphorylation and proliferation through ADAM-17 tumor necrosis factor α-converting enzyme (TACE) activation and heparin-bound epidermal growth factor-like growth factor (HB-EGF) shedding in mesangial cells. J Biol Chem 281: 21004-21012, 2006.
9. Gschwind A, Hart S, Fischer OM, Ullrich A. TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. EMBO J 22: 2411-2421, 2003.
10. Gschwind A, Prenzel N, Ullrich A. Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation. Cancer Res 62: 6329-6336, 2002.
11. Hanawa M, Suzuki S, Dobashi Y, Yamane T, Kono K, Enomoto N, Ooi A. EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus. Int J Cancer 118: 1173-1180, 2006.
12. Jeanneteau F, Chao MV. Promoting neurotrophic effects by GPCR ligands. Novartis Found Symp 276: 181-189, 2006.
13. Kalmes A, Vesti BR, Daum G, Abraham JA, Clowes AW. Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor. Circ Res 87: 92-98, 2000.
14. Kanno H, Norikawa Y, Hodges RR, Zoukhri D, Shatos MA, Rios JD, Dartt DA. Cholinergic agonists transactivate EGFR and stimulate MAPK to induce goblet cell secretion. Am J Physiol Cell Physiol 284: C988-C998, 2003.
15. Keely SJ, Uribe JM, Barrett KE. Carbachol stimulates transactivation of epidermal growth factor receptor and mitogen-activated protein kinase in T84 cells. Implications for carbachol-stimulated chloride secretion. J Biol Chem 273: 27111-27117, 1998.
16. Kelly DJ, Cox AJ, Gow RM, Zhang Y, Kemp BE, Gilbert RE. Platelet-derived growth factor receptor transactivation mediates the trophic effects of angiotensin II in vivo. Hypertension 44: 195-202, 2004.
17. Kue PF, Taub JS, Harrington LB, Polakiewicz RD, Ullrich A, Daaka Y. Lysophosphatidic acid-regulated mitogenic ERK signaling in androgen-insensitive prostate cancer PC-3 cells. Int J Cancer 102: 572-579, 2002.
18. α12. Mol Cell Biol 26: 50-62, 2006.
19. Le Gall SM, Auger R, Dreux C, Mauduit P. Regulated cell surface pro-EGF ectodomain shedding is a zinc metalloprotease-dependent process. J Biol Chem 278: 45255-45268, 2003.
20. Lee MH, Murphy G. Matrix metalloproteinases at a glance. J Cell Sci 117: 4015-4016, 2003.
21. Leserer M, Gschwind A, Ullrich A. Epidermal growth factor receptor signal transactivation. IUBMB Life 49: 405-409, 2000.
22. Lin J, Freeman MR. Transactivation of ErbB1 and ErbB2 receptors by angiotensin II in normal human prostate stromal cells. Prostate 54: 1-7, 2003.
23. Lucchesi PA, Sabri A, Belmadani S, Matrougui K. Involvement of metalloproteinases 2/9 in epidermal growth factor receptor transactivation in pressure-induced myogenic tone in mouse mesenteric resistance arteries. Circulation 110: 3587-3593, 2004.
24. Luo L, Yano N, Luo JZ. The molecular mechanism of EGF receptor activation in pancreatic β-cells by thyrotropin-releasing hormone. Am J Physiol Endocrinol Metab 290: E889-E899, 2006.
25. Madarame J, Higashiyama S, Kiyota H, Madachi A, Toki F, Shimomura T, Tani N, Oishi Y, Matsuura N. Transactivation of epidermal growth factor receptor after heparin-binding epidermal growth factor-like growth factor shedding in the migration of prostate cancer cells promoted by bombesin. Prostate 57: 187-195, 2003.
26. Meneray MA, Fields TY. Adrenergic stimulation of lacrimal protein secretion is mediate by G(q/11)alpha and G(s)alpha. Curr Eye Res 21: 602-607, 2000.
27. Miyamoto S, Hirata M, Yamazaki A, Kageyama T, Hasuwa H, Mizushima H, Tanaka Y, Yagi H, Sonoda K, Kai M, Kanoh H, Nakano H, Mekada E. Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy. Cancer Res 64: 5720-5727, 2004.
28. Mori K, Kitayama J, Shida D, Yamashita H, Watanabe T, Nagawa H. Lysophosphatidic acid-induced effects in human colon carcinoma DLD1 cells are partially dependent on transactivation of epidermal growth factor receptor. J Surg Res 132: 56-61, 2006.
29. 2+/calmodulin-dependent transactivation of epidermal growth factor receptor. Circ Res 82: 1338-1348, 1998.
30. Nebibil CG, Choi DS, Dierich A, Hickel P, Le Meur M, Messaddeq N, Launay MM, Maroteaux L. Serotonin 2B receptor is required for heart development. Proc Natl Acad Sci USA 97: 9508-9513, 2006.
31. 1-Adrenergic and cholinergic agonists activate MAPK by separate mechanisms to inhibit secretion in lacrimal gland. Am J Physiol Cell Physiol 284: C168-C178, 2003.
32. Pandiella A, Bosenberg MW, Huang EJ, Besmer P, Massague J. Cleavage of membrane-anchored growth factors involves distinct protease activities regulated through common mechanisms. J Biol Chem 267: 24028-24033, 1992.
33. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, Ullrich A. EGF receptor transactivation by G-protein-coupled receptors requires metalloprotease cleavage of proHB-EGF. Nature 402: 884-888, 1999.
34. Roelle S, Grosse R, Aigner A, Krell HW, Czubayko F, Gudermann T. Matrix metalloproteinases 2 and 9 mediate epidermal growth factor receptor transactivation by gonadotropin-releasing hormone. J Biol Chem 278: 47307-47318, 2003.
35. Sahin U, Weskamp G, Kelly K, Zhou HM, Higashiyama S, Peschon J, Hartmann D, Saftig P, Blobel CP. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 164: 769-779, 2004.
36. Saito S, Frank GD, Motley ED, Dempsey PJ, Utsunomiya H, Inagami T, Eguchi S. Metalloprotease inhibitor blocks angiotensin II-induced migration through inhibition of epidermal growth factor receptor transactivation. Biochem Biophys Res Commun 294: 1023-1029, 2002.
37. Schafer B, Gschwind A, Ullrich A. Multiple G-protein-coupled receptor signals convergeon the epidermal growth factor receptor to promote migration and invasion. Oncogene 23: 991-999, 2004.
38. Schafer B, Marg B, Gschwind A, Ullrich A. Distinct ADAM metalloproteinases regulate G protein-coupled receptor-induced cell proliferation and survival. J Biol Chem 279: 47929-47938, 2004.
39. Stewart JR, O'Brian CA. Protein kinase C-α mediates epidermal growth factor receptor transactivation in human prostate cancer cells. Mol Cancer Ther 4: 726-732, 2005.
40. Sukocheva O, Wadham C, Holmes A, Albanese N, Verrier E, Feng F, Bernal A, Derian CK, Ullrich A, Vadas MA, Xia P. Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1. J Cell Biol 173: 301-310, 2006.
41. Verbeek BS, Adriaansen-Slot SS, Vroom TM, Beckers T, Rijksen G. Overexpression of EGFR and c-erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts. FEBS Lett 425: 145-150, 1998.
42. Yang X, Zhu MJ, Sreejayan N, Ren J, Du M. Cholinergic agonists transactivate EGFR and stimulate MAPK to induce goblet cell secretion. Mol Cell 20: 263-270, 2005.
43. Zhao Y, He D, Saatian B, Watkins T, Spannhake EW, Pyne NJ, Natarajan V. Regulation of lysophosphatidic acid-induced epidermal growth factor receptor transactivation and interleukin-8 secretion in human bronchial epithelial cells by protein kinase Cδ, Lyn kinase and matrix metalloproteinases. J Biol Chem 281: 19501-19511, 2006.